Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
09/10/2009 | US20090227635 Therapeutic compounds |
09/10/2009 | US20090227616 Inhibitors of akt activity |
09/10/2009 | US20090227592 Compounds effecting glucokinase |
09/10/2009 | US20090227585 Substituted n-heterocycle derivatives and methods of their use |
09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
09/10/2009 | US20090227557 Substituted beta-lactams |
09/09/2009 | EP2098520A1 Photochromic dichroic naphtho-pyrans and optical articles containing them |
09/09/2009 | EP2098508A1 Cyclic derivatives as modulators of chemokine receptor activity |
09/09/2009 | EP2097408A1 Improved process for eprosartan |
09/09/2009 | EP2097405A2 Anti-viral compounds |
09/09/2009 | EP2097395A1 Process for the preparation of valsartan and intermediate products |
09/09/2009 | EP2097382A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase |
09/09/2009 | EP1893197B1 Chromane substituted benzimidazole derivatives as acid pump antagonists |
09/09/2009 | EP1449833B1 Bisimide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition |
09/09/2009 | EP1379243B1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
09/09/2009 | CN101528728A 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents |
09/09/2009 | CN101525393A Oxime ester photoinitiator and preparation method thereof |
09/09/2009 | CN101525334A Organic solar cell material and preparation thereof |
09/09/2009 | CN101525333A Synthesis method of metixene hydrochloride |
09/09/2009 | CN100537566C Organic dye, its production and use |
09/09/2009 | CN100537527C Aryl and biaryl compounds having MCH modulatory activity |
09/08/2009 | US7585888 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
09/08/2009 | US7585860 Substituted oxazolidinones and their use in the field of blood coagulation |
09/08/2009 | US7585859 PDE4B inhibitors and uses therefor |
09/08/2009 | US7585858 N-((4-((( 1R)-3 -(dimethylamino)-1-((phenylsulfanyl)methyl)propyl)amino)-3-nitrophenyl)sulfonyl)-4-(4-(2-fluorobenzyl)-4-methoxy-1-piperidinyl)benzenecarboximidamide; trigger apoptosis through the inhibition of the Bcl family of proteins |
09/08/2009 | US7585853 Compounds having selective inhibiting effect at GSK3 |
09/08/2009 | CA2440931C Hiv protease inhibitors based on amino acid derivatives |
09/08/2009 | CA2387351C Indole derivatives as tyrosine kinase inhibitors |
09/08/2009 | CA2373665C Substituted thienocycloalk(en)ylamino-1,3,5-triazine |
09/08/2009 | CA2342739C Azetidine derivatives, preparation and medicines containing them |
09/08/2009 | CA2316388C Tetrahydrobenzindole derivative |
09/08/2009 | CA2213466C Inhibitors of microsomal triglyceride transfer protein and method |
09/08/2009 | CA2141731C Antifungal agents, processes for the preparation thereof, and intermediates |
09/03/2009 | WO2009107764A1 Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens |
09/03/2009 | WO2009107391A1 Compound having 6-membered aromatic ring |
09/03/2009 | WO2009107387A1 2-oxochromene derivative |
09/03/2009 | WO2009106817A2 Compound |
09/03/2009 | WO2009106586A1 Quinolines as inhibitors of farnesyl pyrophosphate synthase |
09/03/2009 | WO2009106534A1 Novel heterocyclic carboxamides as m1 agonists |
09/03/2009 | WO2009106470A2 Angiotensin ii receptor antagonists |
09/03/2009 | WO2009106203A1 Glucokinase activators |
09/03/2009 | WO2009105824A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
09/03/2009 | WO2009105823A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
09/03/2009 | WO2009070045A3 Imidazole derivatives, process for their preparation, and thier pharmaceutical use |
09/03/2009 | WO2009058937A3 Heteroaryl ethers and processes for their preparation |
09/03/2009 | US20090221661 Phosphodiesterase 4 inhibitors |
09/03/2009 | US20090221643 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia |
09/03/2009 | US20090221572 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands |
09/03/2009 | US20090221564 Heterocyclic Compounds and Their Use in the Treatment of Cardiovascular Disease |
09/03/2009 | US20090220662 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers |
09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
09/03/2009 | CA2717011A1 Quinolines as inhibitors of farnesyl pyrophosphate synthase |
09/03/2009 | CA2716898A1 Compound having 6-membered aromatic ring |
09/03/2009 | CA2716647A1 Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens |
09/03/2009 | CA2716599A1 Glucokinase activators |
09/03/2009 | CA2716316A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
09/03/2009 | CA2716250A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
09/03/2009 | CA2714607A1 Hexahydrocyclopentyl[f]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators |
09/03/2009 | CA2714058A1 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease |
09/03/2009 | CA2712689A1 Angiotensin ii receptor antagonists |
09/02/2009 | EP2096110A1 Acridane-9-dithiocarboxylate derivatives for generating chemiluminescence with a peroxidase |
09/02/2009 | EP2096108A1 Novel organic electroluminescent compounds and organic electroluminscent device using the same |
09/02/2009 | EP2094714A2 Substituted thienopyridone compounds with antibacterial activity |
09/02/2009 | EP2094692A2 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof |
09/02/2009 | EP2094670A1 Heterocyclyc sulfonamides having edg-i antagonistic activity |
09/02/2009 | EP2094659A1 Heteroaryl (substituted) alkyl n-substituted sulfoximines as insecticides |
09/02/2009 | EP2094272A2 Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors |
09/02/2009 | EP1937672B1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
09/02/2009 | EP1909792B1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
09/02/2009 | EP1899322B1 Isoquinoline derivatives as inhibitors of rho-kinase |
09/02/2009 | EP1888574B1 New antibiotic derivatives |
09/02/2009 | EP1572215B1 Benzo[d]azepine derivatives for the treatment of neurological disorders |
09/02/2009 | EP1470137B1 Edg receptor agonists |
09/02/2009 | EP1282617B1 Hydantoin derivatives with affinity for somatostatin receptors |
09/02/2009 | CN101522669A Therapeutic lactams |
09/02/2009 | CN101519403A Method for synthesis tioconazole |
09/02/2009 | CN101519402A Thiochromone compound, synthetic method and application thereof in preparing antifungal medicaments |
09/02/2009 | CN101519386A Large conductance calcium-activated K channel opener |
09/02/2009 | CN100534990C Pyrrolidone carboxamides |
09/01/2009 | US7582770 3-(2-{1-[(3-Cyclopentyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carbonyl)amino]cyclobutyl}-1-methyl-1H-benzoimidazol-5-yl)acrylic acid; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
09/01/2009 | US7582765 Aryl aniline β2 adrenergic receptor agonists |
09/01/2009 | US7582761 Vanilloid receptor ligands and their use in treatments |
09/01/2009 | US7582669 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
09/01/2009 | US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
09/01/2009 | US7582658 Bicyclic compound |
09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
09/01/2009 | US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring |
09/01/2009 | US7582645 Pyrimidine derivatives for treatment of hyperproliferative disorders |
09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
09/01/2009 | US7582632 Tri(cyclo) substituted amide compounds |
09/01/2009 | US7582627 3-aminoquinazolin-2,4-dione antibacterial agents |
09/01/2009 | US7582624 Benzodiazepine derivatives and pharmaceutical compositions containing them |
09/01/2009 | US7582589 3-carbonylaminothiophenes and their use as fungicides |
09/01/2009 | CA2506491C Novel derivatives of pyrrolidines and thiazolidines, process for preparing them and pharmaceutical compositions containing them |
09/01/2009 | CA2367368C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
08/27/2009 | WO2009105440A1 Beta-lactams for reducing intraocular pressure |
08/27/2009 | WO2009105438A1 Therapeutic substituted lactams |
08/27/2009 | WO2009104819A1 Benzodiazepine compound and pharmaceutical composition |
08/27/2009 | WO2009104733A1 Organic electroluminescent device material and organic electroluminescent device |